In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all
current investors, traders, and shareholders of Great Plains Energy
Inc (NYSE:GXP), Flowers Foods, Inc. (NYSE:FLO), Hasbro, Inc.
(NASDAQ:HAS), Acadia Healthcare Company, Inc. (NASDAQ:ACHC), DXC
Technology Company. (NYSE:DXC), and Alnylam Pharmaceuticals, Inc.
(NASDAQ:ALNY), including updated fundamental summaries,
consolidated fiscal reporting, and fully-qualified certified
analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available
to readers at the links below.
GXP DOWNLOAD:
http://Fundamental-Markets.com/register/?so=GXP
FLO DOWNLOAD:
http://Fundamental-Markets.com/register/?so=FLO
HAS DOWNLOAD:
http://Fundamental-Markets.com/register/?so=HAS
ACHC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ACHC
DXC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=DXC
ALNY DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ALNY
(You may have to copy and paste the link into your browser and
hit the [ENTER] key)
The new research reports from Fundamental
Markets, available for free download at the links above, examine
Great Plains Energy Inc (NYSE:GXP), Flowers Foods, Inc. (NYSE:FLO),
Hasbro, Inc. (NASDAQ:HAS), Acadia Healthcare Company, Inc.
(NASDAQ:ACHC), DXC Technology Company. (NYSE:DXC), and Alnylam
Pharmaceuticals, Inc. (NASDAQ:ALNY) on a fundamental level and
outlines the overall demand for their products and services in
addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts
from the recently released reports are available to today's readers
below.
-----------------------------------------
Important Notice: the following excerpts are
not designed to be standalone summaries and as such, important
information may be missing from these samples. All information in
this release was accessed November 16th, 2017. Please download the
entire research report, free of charge, to ensure you are reading
all relevant material information. All amounts in millions (except
per share amounts).
-----------------------------------------
GREAT PLAINS ENERGY INC (GXP) REPORT
OVERVIEW
Great Plains Energy's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Great Plains Energy reported revenue of
$857.20 vs $856.80 (up 0.05%) and diluted earnings per share $0.02
vs $0.86 (down 97.67%). For the twelve months ended December 31st,
2016 vs December 31st, 2015, Great Plains Energy reported revenue
of $2,676.00 vs $2,502.20 (up 6.95%) and diluted earnings per share
$1.61 vs $1.37 (up 17.52%). Great Plains Energy is expected to
report earnings on February 22nd, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $0.13. The estimated EPS forecast for
the next fiscal year is $1.82 and is expected to report on February
22nd, 2018.
To read the full Great Plains Energy Inc (GXP) report, download
it here:
http://Fundamental-Markets.com/register/?so=GXP
-----------------------------------------
FLOWERS FOODS, INC. (FLO) REPORT
OVERVIEW
Flowers Foods' Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Flowers Foods reported revenue of $932.82
vs $918.79 (up 1.53%) and diluted earnings per share -$0.16 vs
$0.19. For the twelve months ended December 31st, 2016 vs December
31st, 2015, Flowers Foods reported revenue of $3,926.89 vs
$3,778.51 (up 3.93%) and diluted earnings per share $0.78 vs $0.89
(down 12.36%). Flowers Foods is expected to report earnings on
February 12th, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter
last year was $0.16. The estimated EPS forecast for the next fiscal
year is $0.92 and is expected to report on February 12th, 2018.
To read the full Flowers Foods, Inc. (FLO) report, download it
here:
http://Fundamental-Markets.com/register/?so=FLO
-----------------------------------------
HASBRO, INC. (HAS) REPORT
OVERVIEW
Hasbro's Recent Financial Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Hasbro reported revenue of $1,791.50 vs
$1,679.76 (up 6.65%) and diluted earnings per share $2.09 vs $2.03
(up 2.96%). For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Hasbro reported revenue of $5,019.82 vs
$4,447.51 (up 12.87%) and diluted earnings per share $4.34 vs $3.57
(up 21.57%). Hasbro is expected to report earnings on February 5th,
2018. The report will be for the fiscal period ending December
31st, 2017. The reported EPS for the same quarter last year was
$1.64. The estimated EPS forecast for the next fiscal year is $5.26
and is expected to report on February 5th, 2018.
To read the full Hasbro, Inc. (HAS) report, download it here:
http://Fundamental-Markets.com/register/?so=HAS
-----------------------------------------
ACADIA HEALTHCARE COMPANY, INC. (ACHC) REPORT
OVERVIEW
Acadia Healthcare's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Acadia Healthcare reported revenue of
$716.71 vs $734.67 (down 2.44%) and diluted earnings per share
$0.52 vs -$1.36. For the twelve months ended December 31st, 2016 vs
December 31st, 2015, Acadia Healthcare reported revenue of
$2,810.91 vs $1,794.49 (up 56.64%) and diluted earnings per share
$0.07 vs $1.64 (down 95.73%). Acadia Healthcare is expected to
report earnings on February 22nd, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the
same quarter last year was $0.59. The estimated EPS forecast for
the next fiscal year is $2.50 and is expected to report on February
22nd, 2018.
To read the full Acadia Healthcare Company, Inc. (ACHC) report,
download it here:
http://Fundamental-Markets.com/register/?so=ACHC
-----------------------------------------
DXC TECHNOLOGY COMPANY. (DXC) REPORT
OVERVIEW
DXC Technology's Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, DXC Technology reported revenue of
$6,163.00 vs $1,871.00 (up 229.4%) and diluted earnings per share
$0.88 vs $0.10 (up 780%). For the twelve months ended March 31st,
2017 vs March 31st, 2016, DXC Technology reported revenue of
$7,607.00 vs $7,106.00 (up 7.05%) and diluted earnings per share
-$0.88 vs $1.78. DXC Technology is expected to report earnings on
February 1st, 2018. The report will be for the fiscal period ending
December 31st, 2017. The reported EPS for the same quarter last
year was $0.81. The estimated EPS forecast for the next fiscal year
is $8.43 and is expected to report on May 24th, 2018.
To read the full DXC Technology Company. (DXC) report, download
it here:
http://Fundamental-Markets.com/register/?so=DXC
-----------------------------------------
ALNYLAM PHARMACEUTICALS, INC. (ALNY) REPORT
OVERVIEW
Alnylam Pharmaceuticals' Recent Financial
Performance
For the three months ended September 30th, 2017
vs September 30th, 2016, Alnylam Pharmaceuticals reported revenue
of $17.10 vs $13.65 (up 25.24%) and diluted earnings per share
-$1.34 vs -$1.21. For the twelve months ended December 31st, 2016
vs December 31st, 2015, Alnylam Pharmaceuticals reported revenue of
$47.16 vs $41.10 (up 14.75%) and diluted earnings per share -$4.79
vs -$3.45. Alnylam Pharmaceuticals is expected to report earnings
on February 14th, 2018. The report will be for the fiscal period
ending December 31st, 2017. The reported EPS for the same quarter
last year was -$1.32. The estimated EPS forecast for the next
fiscal year is -$5.83 and is expected to report on February 14th,
2018.
To read the full Alnylam Pharmaceuticals, Inc. (ALNY) report,
download it here:
http://Fundamental-Markets.com/register/?so=ALNY
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members
and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best
information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial
experience and includes top financial writers, FINRA® BrokerCheck®
certified professionals with current and valid CRD® number
designations, as well as Chartered Financial Analyst® (CFA®)
designation holders, to ensure up to date factual information for
active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff
are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and
Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and
registered FINRA® members holding duly issued CRD® numbers. Current
licensed status of several Registered Members at Fundamental
Markets have been independently verified by an outside audit firm,
including policy and audit records duly executed by Registered
Members. Complaints, concerns, questions, or inquiries regarding
this release should be directed to Fundamental Markets' Compliance
department by Phone, at +1 667-401-0010, or by E-mail at
compliance@fundamental-markets.com.
LEGAL NOTICES
Information contained herein is not an offer or
solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets
affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no
representations as to the completeness, accuracy, or timeliness of
the material provided and all materials are subject to change
without notice. Fundamental Markets has not been compensated for
the publication of this press release by any of the above mentioned
companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any
activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our
website.
Media Contact: Andrew Duffie, Media Department
Office: +1 667-401-0010 E-mail:
andrew.duffie@fundamental-markets.com
Ⓒ 2017 Fundamental Markets. All Rights Reserved. For
republishing permissions, please contact a partner network manager
at partnership@fundamental-markets.com.
CFA® and Chartered Financial Analyst® are registered
trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks
owned by Financial Industry Regulatory Authority, Inc.
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From Apr 2024 to May 2024
Alnylam Pharmaceuticals (NASDAQ:ALNY)
Historical Stock Chart
From May 2023 to May 2024